|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 9/14 | (2006.01) |
| A61K 31/47 | (2006.01) | ||
| A61P 19/10 | (2006.01) | ||
| A61P 19/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/44 | (2006.01) |
| (11) | Patento numeris | 2464337 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10708442.8 |
| Europos patento paraiškos padavimo data | 2010-02-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-06-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-01-09 |
| (46) | Apibrėžties vertimo paskelbimo data | 2019-05-10 |
| (86) | Numeris | PCT/US2010/024609 |
| Data | 2010-02-18 |
| (87) | Numeris | WO 2011/019413 |
| Data | 2011-02-17 |
| (30) | Numeris | Data | Šalis |
| US2009/000462 | 2009-08-13 | WO | |
| 583066 | 2009-08-13 | US |
| (72) |
ROWE, William, US
HURTER, Patricia, US
YOUNG, Christopher, R., US
DINEHART, Kirk, US
VERWIJS, Marinus, Jacobus, US
OVERHOFF, Kirk, US
GROOTENHUIS, Peter, D. J., US
BOTFIELD, Martyn, US
GROSSI, Alfredo, US
ZLOKARNIK, Gregor, US
VAN GOOR, Fredrick F., US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, Boston, MA 02210,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido tabletės forma, skirta panaudoti cistinės fibrozės gydymui |
| Tablet formulation of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide for use in the treatment of cystic fibrosis |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-02-03 | 16 | 347.00 EUR |
| 2026-02-18 |